亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Outcomes and prognostic factors in initially unresectable hepatocellular carcinoma treated using conversion therapy with lenvatinib and TACE plus PD-1 inhibitors

医学 肝细胞癌 内科学 伦瓦提尼 多元分析 肿瘤科 胃肠病学 无进展生存期 肿瘤进展 实体瘤疗效评价标准 队列 泌尿科 外科 总体生存率 索拉非尼 癌症 进行性疾病 化疗
作者
Xingzhi Li,Jie Chen,Xiaobo Wang,Tao Bai,Shaolong Lu,Tao Wei,Zhihong Tang,Chengwen Huang,Bin Zhang,Bowen Liu,Le‐Qun Li,Feixiang Wu
出处
期刊:Frontiers in Oncology [Frontiers Media]
卷期号:13: 1110689-1110689 被引量:21
标识
DOI:10.3389/fonc.2023.1110689
摘要

Purpose To evaluate the outcomes and prognostic factors for patients using conversion therapy with lenvatinib combined with transcatheter arterial chemoembolization (TACE) plus programmed cell death protein-1 (PD-1) inhibitors (LTP) for initially unresectable hepatocellular carcinoma (iuHCC). Methods Data on 94 consecutive patients with iuHCC who received LTP conversion therapy from November 2019 to September 2022 were retrospectively analyzed. Early tumor response was reported when patients showed complete or partial response at the time of their first follow-up (4–6 weeks) after initial treatment, in accordance with mRECIST. The endpoints consisted of conversion surgery rate, overall survival (OS), and progression-free survival (PFS). Results Early tumor response was found in 68 patients (72.3%) and not in the remaining 26 patients (27.7%) in the entire cohort. Early responders had a significantly higher conversion surgery rate than non-early responders (44.1% vs. 7.7%, p=0.001). Early tumor response was the only factor independently associated with successful conversion resection, as indicated by multivariate analysis (OR=10.296; 95% CI: 2.076–51.063; p=0.004). Survival analysis showed that early responders had longer PFS (15.4 vs. 7.8 months, p=0.005) and OS (23.1 vs. 12.5 months, p=0.004) than non-early responders. Early responders who underwent conversion surgery also had significantly longer median PFS and OS (not reached, not reached) than those who did not (11.2 months, p=0.004; 19.4 months, p<0.001). In multivariate analyses, early tumor response was identified as an independent prognostic factor for longer OS (HR=0.404, 95% CI: 0.171–0.954; p=0.039). Successful conversion surgery was also an independent predictive factor for longer PFS (HR=0.248, 95% CI: 0.099–0.622; p=0.003) and OS (HR=0.147, 95% CI: 0.039–0.554; p=0.005). Conclusions Early tumor response is an important predictive marker for successful conversion surgery and prolonged survival in patients with iuHCC treated using LTP conversion therapy. Conversion surgery is necessary to improve survival during conversion therapy, particularly for early responders.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
盼盼完成签到,获得积分10
11秒前
ramsey33完成签到 ,获得积分10
19秒前
酷酷云朵完成签到,获得积分10
20秒前
30秒前
帅气忻完成签到 ,获得积分10
1分钟前
1分钟前
SCI的芷蝶完成签到 ,获得积分10
1分钟前
1分钟前
1分钟前
1分钟前
1分钟前
1分钟前
蔓越莓奶酥完成签到,获得积分20
1分钟前
1分钟前
大个的应助被whc采纳,获得10
1分钟前
深情安青的应助被Yang采纳,获得10
2分钟前
2分钟前
2分钟前
whc发布了新的文献求助10
2分钟前
呆萌的若剑完成签到,获得积分10
2分钟前
2分钟前
开朗如猪猪完成签到 ,获得积分10
2分钟前
saflgf完成签到,获得积分10
2分钟前
Doctor.TANG完成签到 ,获得积分10
3分钟前
3分钟前
3分钟前
林好人完成签到 ,获得积分10
3分钟前
nk完成签到 ,获得积分10
3分钟前
欢呼的听枫完成签到,获得积分10
3分钟前
NN完成签到,获得积分10
4分钟前
4分钟前
外向如雪完成签到,获得积分10
4分钟前
隐形曼青的应助被gtgyh采纳,获得10
4分钟前
5分钟前
5分钟前
5分钟前
5分钟前
5分钟前
5分钟前
gtgyh发布了新的文献求助10
5分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 2000
Sex, Aging, and Death in a Medieval Medical Compendium: Trinity College Cambridge MS R.14.52, Its Texts, Language, and Scribe 500
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
基于界面调控的高效湿气发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8190148
求助须知:如何正确求助?哪些是违规求助? 9577257
关于积分的说明 21852289
捐赠科研通 7788541
什么是DOI,文献DOI怎么找? 3436279
关于科研通互助平台的介绍 2560044
邀请新用户注册赠送积分活动 2482880